hantacount
ライブ追跡
ライブ16総症例数3死亡者数14感染国数19%致命率
疾患比較

Hantavirus (Andes) vs COVID-19

アンデスハンタウイルスは、最もよく質問される他の新興ウイルスと実際にどう比較されるのか?すべての数値はWHOとCDCのファクトシートから直接引用。

最終審査: 2026-05-09

Hantavirus (Andes) vs COVID-19

7つのウイルス性疾患を致命率・R0・潜伏期間・感染経路・治療法・保有宿主で比較。
指標ANDVCOVID
致命率30–40%~0.5–1% IFR (ancestral, pre-vaccine)
R0(基本再生産数)<1 (rare P2P clusters)2–3 (ancestral); higher for later variants
潜伏期間2–4 weeks (up to 6)2–14 days (median 5)
感染経路Inhaled rodent excreta; rare person-to-person (ANDV only)Respiratory aerosols and droplets; pre-symptomatic spread
ヒトからヒトへの感染限定的あり
治療法の有無Supportive care, oxygen, ECMO; ribavirin investigationalAntivirals (nirmatrelvir/ritonavir, remdesivir); supportive care
ワクチンの有無None licensedMultiple licensed mRNA, viral-vector and protein subunit vaccines
地理的分布Argentina, Chile, with imported clusters worldwide (2026)Global pandemic since 2020; now endemic seasonal circulation
最初の確認年19952019
ウイルスファミリーHantaviridae (Bunyavirales)Coronaviridae
保有宿主Long-tailed pygmy rice rat (Oligoryzomys longicaudatus)Bats (likely ancestral); intermediate host debated

Hantavirus (Andes virus, ANDV)

ANDV

Andes virus is the only hantavirus with documented person-to-person transmission. The 2026 MV Hondius cluster is being closely watched because its cruise-ship setting matches the close-contact conditions where ANDV chains have appeared historically.

最初の確認年
1995
ウイルスファミリー
Hantaviridae (Bunyavirales)
保有宿主
Long-tailed pygmy rice rat (Oligoryzomys longicaudatus)

COVID-19 (SARS-CoV-2)

COVID

SARS-CoV-2 spreads efficiently before symptoms begin, which is exactly the property that drove the 2020 pandemic. Hantaviruses lack this trait, which is the single biggest reason ANDV is not expected to behave like COVID.

最初の確認年
2019
ウイルスファミリー
Coronaviridae
保有宿主
Bats (likely ancestral); intermediate host debated

出典:WHOおよび米国CDCのトピックページ。

疾患比較